A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer.
Altomare I, Bendell JC, Bullock KE, Uronis HE, Morse MA, Hsu SD, Zafar SY, Blobe GC, Pang H, Honeycutt W, Sutton L, Hurwitz HI.
Altomare I, et al. Among authors: bendell jc.
Oncologist. 2011;16(8):1131-7. doi: 10.1634/theoncologist.2011-0078. Epub 2011 Jul 27.
Oncologist. 2011.
PMID: 21795432
Free PMC article.
Clinical Trial.